Panacea Life Sciences Holdings, Inc.
PLSH· OTC
Filed May 15, 2017 · 10-Q · 45 days after period end · 0001654954-17-004665
| Metric | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Net Income | -$601.01K | -$234.82K | -$63.81K |
| EPS Diluted | -$0.02 | -$0.54 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end